CDMO Activity Tracker: Axplora enhances ADC capacities, Quotient beefs up HPAPI capabilities; Evonik, EUROAPI forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

Ritonavir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 24 USDMF, 12 CEP/COS, 1 JDMF, 10 EU WC, 3 KDMF, 9 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 41 FDA Orange Book, 18 Europe, 7 Canada, 1 Australia, 25 South Africa, 15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 100MG;25MG, TABLET;ORAL - 200MG;50MG, TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 3 Rochem International Inc, 1 SPI Pharma, 10 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 2 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 3 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 Bioplus Life Sciences, 1 Clariant, 12 Corel Pharma Chem, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 15 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Coating Systems & Additives, 34 Solubilizers, 29 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 22 Parenteral, 21 Film Formers & Plasticizers, 19 Topical, 17 Emulsifying Agents, 17 Thickeners and Stabilizers, 12 Taste Masking, 12 Direct Compression, 11 Granulation, 11 Lubricants & Glidants, 10 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 6 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 154 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

24 APIs, 9 FDF Dossiers

PATENTS & EXCLUSIVITIES

27 US Patents, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Ajinomoto Company	Japan	AJINOMOTO CO INC	11677	A-84538.0 (RITONAVIR)	1995-09-25	Inactive	II	N/A
28/03/2025	Arene Lifesciences	India	ARENE LIFE SCIENCES PRIVATE LTD	34846	RITONAVIR USP	2020-05-03	Active	II	N/A

Ritonavir

Ritonavir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

24 USDMF

12 CEP/COS

1 JDMF

10 EU WC

3 KDMF

9 NDC API

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

63 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers

41 FDA Orange Book

18 Europe

7 Canada

1 Australia

25 South Africa

15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 12.5MG;75MG;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG;25MG

TABLET;ORAL - 200MG;50MG

TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

3 Rochem International Inc

1 SPI Pharma

10 DKSH

1 PMC Isochem

1 Pharm-RX Chemical

2 Faran Shimi Pharmaceutical

6 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

3 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

1 Pramukh Pharmachem

1 Zeal MediPharma

4 ACG Worldwide

7 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 Bioplus Life Sciences

1 Clariant

12 Corel Pharma Chem

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

6 Ideal Cures Pvt Ltd

14 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

4 Novo Excipients

2 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

3 Roquette

15 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Sigachi Industries

TABLET;ORAL - 12.5MG;75MG;50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE;8.33MG;50MG;33.33MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons